✦ LIBER ✦

Experimental study on interleukin 6 activity against tumor; Regulation of interleukin-2 induced lak cell activity

✍ Scribed by Lisheng Lu; Zhengyan Cui; Ling Zhang; Denghua Li; Zhigang Tian

Book ID: 112974455
Publisher: Chinese Anti-Cancer Association
Year: 1993
Tongue: English
Weight: 234 KB
Volume: 5
Category: Article
ISSN: 1000-9604
DOI: 10.1007/bf03023757

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cytotoxicity of interleukin 2-induced ly

Cytotoxicity of interleukin 2-induced lymphokine-activated killer (LAK) cells against human leukemia and augmentation of killing by interferons and tumor necrosis factor

✍ Johannes V. Teichmann; Wolf-Dieter Ludwig; Eckhard Thiel 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 986 KB

Randomized controlled study with Interle

Randomized controlled study with Interleukin 2 and Lymphokine activated killer (LAK) cells against postoperative primary lung cancer patients

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 135 KB

The cytotoxic effect of R-interleukin-2

The cytotoxic effect of R-interleukin-2 activated lymphocytes (LAK cells) on human urothelial cells

📂 Article 📅 1988 🏛 Elsevier Science ⚖ 38 KB

Interleukin-6 does not support interleuk

Interleukin-6 does not support interleukin-2 induced generation of human lymphokine-activated killer cells

✍ Hans-G. Klingemann; Elaine Wong 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 399 KB

Combined effect of interleukin 2 and pro

Combined effect of interleukin 2 and prolactin on generation of LAK activity by NK cells

✍ Matera, L.; Bellone, G.; Cesano, A.; Oberholtzer, E. 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Anti-tumor activity of interleukin-2-pro

Anti-tumor activity of interleukin-2-producing tumor cells and recombinant interleukin 12 against mouse glioma cells located in the central nervous system

✍ Tetsuro Kikuchi; Tatsuhiro Joki; Saburo Saitoh; Yuichi Hata; Toshiaki Abe; Naoki 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 134 KB 👁 2 views

Interleukin 12 (IL-12) exhibits anti-tumor activity in a variety of laboratory models. Although IL-12 itself activates strong anti-tumor activity, the combination of vaccine therapy with IL-2-transduced tumor cells and systemic rIL-12 has been shown to cure tumor-bearing mice more effectively than e